Skip to main content
SpringerLink
Log in

Complications of Peritoneal Dialysis

  • Chapter
  • First Online:
Primer on Nephrology

Abstract

Peritoneal dialysis (PD) is an important dialysis modality that provides individuals with stage 5 kidney disease the opportunity to take a greater role in their own care and be relatively independent from the hospital. Although there is no demonstrable difference in survival between patients who choose PD compared with those who choose hemodialysis for their treatment, technique failure (TF) with PD limits the time on therapy for many patients. TF can be a consequence of the main complications of PD – these include access problems, infection, limitations on solute clearance and ultrafiltration as well as challenges for the individual in managing their treatment. International guidelines present the best evidence to reduce the risk of and to manage these complications which are most appropriately managed through center-based continuous quality improvement. Ongoing research studies including the Peritoneal Dialysis Outcomes and Practice Patterns Study aim to find the best clinical management approaches to deliver PD with the lowest possible risk of TF.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Notes

  1. 1.

    The peritoneal equilibration test measures the dialysate to plasma ratio of creatinine (D/P creatinine) at the end of a 4-hour dwell using a dialysate with a 2.27% glucose concentration.

References

  1. Yeates K, Zhu N, Vonesh E, Trpeski L, Blake P, Fenton S. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant. 2012;27(9):3568–75.

    Article  PubMed  Google Scholar 

  2. Korevaar JC, Feith GW, Dekker FW, van Manen JG, Boeschoten EW, Bossuyt PM, et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int. 2003;64(6):2222–8.

    Article  PubMed  Google Scholar 

  3. Nataatmadja M, Cho Y, Johnson DW. Continuous quality improvement initiatives to sustainably reduce peritoneal dialysis-related infections in Australia and New Zealand. Perit Dial Int. 2016;36(5):472–7.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Kolesnyk I, Dekker FW, Boeschoten EW, Krediet RT. Time-dependent reasons for peritoneal dialysis technique failure and mortality. Perit Dial Int. 2010;30(2):170–7.

    Article  PubMed  Google Scholar 

  5. Perl J, Davies SJ, Lambie M, Pisoni RL, McCullough K, Johnson DW, et al. The peritoneal dialysis outcomes and practice patterns study (PDOPPS): unifying efforts to inform practice and improve global outcomes in peritoneal dialysis. Perit Dial Int. 2016;36(3):297–307.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Williams VR, Quinn R, Callery S, Kiss A, Oliver MJ. The impact of treatment modality on infection-related hospitalization rates in peritoneal dialysis and hemodialysis patients. Perit Dial Int. 2011;31(4):440–9.

    Article  PubMed  Google Scholar 

  7. Hole B, Caskey F, Evans K, Fluck R, Kumwenda M, Steenkamp R, et al. UK renal registry 19th annual report: chapter 12 multisite dialysis access audit in England, Northern Ireland and Wales in 2015 and 2014 PD one year follow-up: national and Centre-specific analyses. Nephron. 2017;137(Suppl 1):269–96.

    Article  PubMed  Google Scholar 

  8. Betjes MG, Habib SM, Boeschoten EW, Hemke AC, Struijk DG, Westerhuis R, et al. Significant decreasing incidence of encapsulating peritoneal sclerosis in the dutch population of peritoneal dialysis patients. Perit Dial Int. 2017;37(2):230–4.

    Article  PubMed  Google Scholar 

  9. Brown EA, Bargman J, van Biesen W, Chang MY, Finkelstein FO, Hurst H, et al. Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis - position paper for ISPD: 2017 update. Perit Dial Int. 2017;37(4):362–74.

    Article  PubMed  Google Scholar 

  10. Figueiredo AE, Bernardini J, Bowes E, Hiramatsu M, Price V, Su C, et al. A syllabus for teaching peritoneal dialysis to patients and caregivers. Perit Dial Int. 2016;36(6):592–605.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Verger C, Ryckelynck JP, Duman M, Veniez G, Lobbedez T, Boulanger E, et al. French peritoneal dialysis registry (RDPLF): outline and main results. Kidney Int Suppl. 2006;103:S12–20.

    Article  Google Scholar 

  12. Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36(5):481–508.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Crabtree JH, Shrestha BM, Chow KM, Figueiredo AE, Povlsen JV, Wilkie M, et al. Creating and maintaining optimal peritoneal dialysis access in the adult patient: 2019 update. Perit Dial Int. 2019;39(5):414–36.

    Article  PubMed  Google Scholar 

  14. Xu G, Tu W, Xu C. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Nephrol Dial Transplant. 2010;25(2):587–92.

    Article  CAS  PubMed  Google Scholar 

  15. Shrestha BM, Brown P, Wilkie M. Surgical peritonitis in patients on peritoneal dialysis. Perit Dial Int. 2008;28(4):331–4.

    Article  PubMed  Google Scholar 

  16. Moraes TP, Pecoits-Filho R, Ribeiro SC, Rigo M, Silva MM, Teixeira PS, et al. Peritoneal dialysis in Brazil: twenty-five years of experience in a single center. Perit Dial Int. 2009;29(5):492–8.

    Article  PubMed  Google Scholar 

  17. Van Biesen W, Veys N, Vanholder R, Lameire N. Peritoneal-dialysis-related peritonitis: the art of rope-dancing. Nephrol Dial Transplant. 2002;17(11):1878–82.

    Article  PubMed  Google Scholar 

  18. Toleman MA. The future of peritoneal dialysis in a moving landscape of bacterial resistance. Perit Dial Int. 2017;37(2):134–40.

    Article  PubMed  Google Scholar 

  19. Ballinger AE, Palmer SC, Wiggins KJ, Craig JC, Johnson DW, Cross NB, et al. Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database Syst Rev. 2014;4:CD005284.

    Google Scholar 

  20. Bailie GR, Eisele G. Pharmacokinetic issues in the treatment of continuous ambulatory peritoneal dialysis-associated peritonitis. J Antimicrob Chemother. 1995;35(5):563–7.

    Article  CAS  PubMed  Google Scholar 

  21. Szeto CC, Li PK, Johnson DW, Bernardini J, Dong J, Figueiredo AE, et al. ISPD catheter-related infection recommendations: 2017 update. Perit Dial Int. 2017;37(2):141–54.

    Article  PubMed  Google Scholar 

  22. Schaefer F, Klaus G, Muller-Wiefel DE, Mehls O. Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS). J Am Soc Nephrol. 1999;10(1):136–45.

    Article  CAS  PubMed  Google Scholar 

  23. Boudville N, Johnson DW, Zhao J, Bieber BA, Pisoni RL, Piraino B, et al. Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the Peritoneal Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2019;34(12):2118–26.

    Article  PubMed  Google Scholar 

  24. Oliver MJ, Verrelli M, Zacharias JM, Blake PG, Garg AX, Johnson JF, et al. Choosing peritoneal dialysis reduces the risk of invasive access interventions. Nephrol Dial Transplant. 2012;27(2):810–6.

    Article  PubMed  Google Scholar 

  25. See EJ, Johnson DW, Hawley CM, Pascoe EM, Badve SV, Boudville N, et al. Risk predictors and causes of technique failure within the first year of peritoneal dialysis: an Australia and New Zealand dialysis and transplant registry (ANZDATA) study. Am J Kidney Dis. 2018;72(2):188–97.

    Article  PubMed  Google Scholar 

  26. Boujelbane L, Fu N, Chapla K, Melnick D, Redfield RR, Waheed S, et al. Percutaneous versus surgical insertion of PD catheters in dialysis patients: a meta-analysis. J Vasc Access. 2015;16(6):498–505.

    Article  PubMed  Google Scholar 

  27. Tullavardhana T, Akranurakkul P, Ungkitphaiboon W, Songtish D. Surgical versus percutaneous techniques for peritoneal dialysis catheter placement: a meta-analysis of the outcomes. Ann Med Surg (Lond). 2016;10:11–8.

    Article  Google Scholar 

  28. Xie H, Zhang W, Cheng J, He Q. Laparoscopic versus open catheter placement in peritoneal dialysis patients: a systematic review and meta-analysis. BMC Nephrol. 2012;13:69.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Shrestha BM, Shrestha D, Kumar A, Shrestha A, Boyes SA, Wilkie ME. Advanced laparoscopic peritoneal dialysis catheter insertion: systematic review and meta-analysis. Perit Dial Int. 2018;38(3):163–71.

    Article  PubMed  Google Scholar 

  30. Crabtree J, Shrestha B, Chow KM, Figueiredo A, Povlsen J, Wilkie M, Abdel-Aal A, Cullis B, Goh BL, Briggs V, Brown E, Dor F. Creating and maintaining optimal peritoneal dialysis access in the adult patient: 2019 update. Perit Dial Int. 2019 - in press Peritoneal Dialysis International.

    Google Scholar 

  31. Campos RP, Chula DC, Riella MC. Complications of the peritoneal access and their management. Contrib Nephrol. 2009;163:183–97.

    Article  PubMed  Google Scholar 

  32. Lew SQ. Hemoperitoneum: bloody peritoneal dialysate in ESRD patients receiving peritoneal dialysis. Perit Dial Int. 2007;27(3):226–33.

    Article  PubMed  Google Scholar 

  33. Greenberg A, Bernardini J, Piraino BM, Johnston JR, Perlmutter JA. Hemoperitoneum complicating chronic peritoneal dialysis: single-center experience and literature review. Am J Kidney Dis. 1992;19(3):252–6.

    Article  CAS  PubMed  Google Scholar 

  34. Keshvari A, Najafi I, Jafari-Javid M, Yunesian M, Chaman R, Taromlou MN. Laparoscopic peritoneal dialysis catheter implantation using a Tenckhoff trocar under local anesthesia with nitrous oxide gas insufflation. Am J Surg. 2009;197(1):8–13.

    Article  PubMed  Google Scholar 

  35. Sharma AP, Mandhani A, Daniel SP, Filler G. Shorter break-in period is a viable option with tighter PD catheter securing during the insertion. Nephrology (Carlton). 2008;13(8):672–6.

    Article  Google Scholar 

  36. Stenvinkel P, Lindholm B, Lonnqvist F, Katzarski K, Heimburger O. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol. 2000;11(7):1303–9.

    Article  CAS  PubMed  Google Scholar 

  37. Galach M, Waniewski J, Axelsson J, Heimburger O, Werynski A, Lindholm B. Mathematical modeling of the glucose-insulin system during peritoneal dialysis with glucose-based fluids. ASAIO J. 2011;57(1):41–7.

    Article  CAS  PubMed  Google Scholar 

  38. Park JT, Chang TI, Kim DK, Lee JE, Choi HY, Kim HW, et al. Metabolic syndrome predicts mortality in non-diabetic patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2010;25(2):599–604.

    Article  PubMed  Google Scholar 

  39. Wang AY, Brimble KS, Brunier G, Holt SG, Jha V, Johnson DW, et al. ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients Part II – management of various cardiovascular complications. Perit Dial Int. 2015;35(4):388–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13(2):470–9.

    Article  PubMed  Google Scholar 

  41. Davies SJ, Phillips L, Russell GI. Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant. 1998;13(4):962–8.

    Article  CAS  PubMed  Google Scholar 

  42. Davies SJ. Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int. 2004;66(6):2437–45.

    Article  CAS  PubMed  Google Scholar 

  43. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI. What really happens to people on long-term peritoneal dialysis? Kidney Int. 1998;54(6):2207–17.

    Article  CAS  PubMed  Google Scholar 

  44. Morelle J, Sow A, Hautem N, Bouzin C, Crott R, Devuyst O, et al. Interstitial fibrosis restricts osmotic water transport in encapsulating peritoneal sclerosis. J Am Soc Nephrol. 2015;26(10):2521–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG. Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol. 2006;17(9):2591–8.

    Article  PubMed  Google Scholar 

  46. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol. 2001;12(5):1046–51.

    Article  CAS  PubMed  Google Scholar 

  47. Wieslander A, Linden T, Kjellstrand P. Glucose degradation products in peritoneal dialysis fluids: how they can be avoided. Perit Dial Int. 2001;21(Suppl 3):S119–24.

    Article  PubMed  Google Scholar 

  48. Pajek J, Kveder R, Bren A, Gucek A, Ihan A, Osredkar J, et al. Short-term effects of a new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study. Perit Dial Int. 2008;28(1):44–52.

    Article  CAS  PubMed  Google Scholar 

  49. Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MWY, et al. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol. 2012;23(6):1097–107.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Seo EY, An SH, Cho JH, Suh HS, Park SH, Gwak H, et al. Effect of biocompatible peritoneal dialysis solution on residual renal function: a systematic review of randomized controlled trials. Perit Dial Int. 2014;34(7):724–31.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int. 2000;20(Suppl 4):S43–55.

    Article  PubMed  Google Scholar 

  52. Hurst H, Summers A, Beaver K, Caress AL. Living with encapsulating peritoneal sclerosis (EPS): the patient’s perspective. Perit Dial Int. 2014;34(7):758–65.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Brown MC, Simpson K, Kerssens JJ, Mactier RA. Encapsulating peritoneal sclerosis in the new millennium: a national cohort study. Clin J Am Soc Nephrol. 2009;4(7):1222–9.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis. 2004;44(4):729–37.

    Article  PubMed  Google Scholar 

  55. Summers AM, Clancy MJ, Syed F, Harwood N, Brenchley PE, Augustine T, et al. Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int. 2005;68(5):2381–8.

    Article  PubMed  Google Scholar 

  56. Lambie M, Teece L, Johnson DW, Petrie M, Mactier R, Solis-Trapala I, et al. Estimating risk of encapsulating peritoneal sclerosis accounting for the competing risk of death. Nephrol Dial Transplant. 2019;34(9):1585–91.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Korte MR, Sampimon DE, Lingsma HF, Fieren MW, Looman CW, Zietse R, et al. Risk factors associated with encapsulating peritoneal sclerosis in Dutch EPS study. Perit Dial Int. 2011;31(3):269–78.

    Article  PubMed  Google Scholar 

  58. Johnson DW, Cho Y, Livingston BE, Hawley CM, McDonald SP, Brown FG, et al. Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes. Kidney Int. 2010;77(10):904–12.

    Article  PubMed  Google Scholar 

  59. Lambie ML, John B, Mushahar L, Huckvale C, Davies SJ. The peritoneal osmotic conductance is low well before the diagnosis of encapsulating peritoneal sclerosis is made. Kidney Int. 2010;78(6):611–8.

    Article  PubMed  Google Scholar 

  60. Gayomali C, Hussein U, Cameron SF, Protopapas Z, Finkelstein FO. Incidence of encapsulating peritoneal sclerosis: a single-center experience with long-term peritoneal dialysis in the United States. Perit Dial Int. 2011;31(3):279–86.

    Article  PubMed  Google Scholar 

  61. Balasubramaniam G, Brown EA, Davenport A, Cairns H, Cooper B, Fan SL, et al. The pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2009;24(10):3209–15.

    Article  PubMed  Google Scholar 

  62. Kawanishi H, Banshodani M, Yamashita M, Shintaku S. Surgical treatment for encapsulating peritoneal sclerosis: 24 years’ experience. Perit Dial Int. 2018;39(2):169–74.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sheffield Kidney Institute, Sheffield, UK

    Sarah Jenkins, Badri Shrestha & Martin Wilkie

  2. Sheffield Teaching Hospitals NHS, Sheffield, UK

    Martin Wilkie

Authors
  1. Sarah Jenkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Badri Shrestha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin Wilkie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin Wilkie .

Editor information

Editors and Affiliations

  1. Department of Renal Medicine, UCL, London, UK

    Mark Harber

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jenkins, S., Shrestha, B., Wilkie, M. (2022). Complications of Peritoneal Dialysis. In: Harber, M. (eds) Primer on Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-030-76419-7_84

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-76419-7_84

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-76418-0

  • Online ISBN: 978-3-030-76419-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation